MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$1,093,000K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Proceeds from sale of vitamin bu...
Amortization expense
Others
Negative Cash Flow Breakdown
Purchase of treasury stock
Acquisitions
Payment of cash dividends
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Net income
736,800
585,300
755,600
413,900
Depreciation expense
89,700
83,200
72,800
67,000
Amortization expense
157,700
155,900
152,400
152,000
Change in fair value of business acquisition liabilities
19,000
-
0
0
Deferred income taxes
36,000
-82,000
-13,800
-117,700
Business exit related impairments
45,600
-
-
-
Vms trade name and other asset impairments-VMSTradename
0
357,100
-
-
Flawless impairment
-
-
0
411,000
Vms trade name and other asset impairments-Flawless Tradename
-
0
-
-
Loss on sale of vitamin business
-58,500
-
-
-
Equity in net earnings of affiliates
7,900
9,100
8,700
12,300
Distributions from unconsolidated affiliates
8,800
8,900
9,500
8,700
Non-cash compensation expense
58,000
59,200
63,600
32,300
Asset impairment charge and other asset write-offs
10,100
12,100
8,900
2,400
Gain on sale of assets
-
-
-
0
Other
6,700
6,200
400
3,200
Subtotal
1,205,600
-
-
-
Accounts receivable
-39,400
81,500
97,400
5,300
Inventories
-56,100
-2,000
-38,500
92,800
Other current assets
-1,200
500
-10,400
-2,500
Accounts payable
2,400
98,600
-
-
Accounts payable and accrued expenses
-
-
55,200
39,900
Accrued expenses
-60,900
-1,100
-
-
Income taxes payable
-5,100
-7,100
-1,800
14,400
Other operating assets and liabilities, net
23,300
18,600
14,200
27,600
Change in working capital
-9,800
-
-
-
Net cash provided by operating activities
1,215,400
1,156,200
1,030,600
885,200
Additions to property, plant and equipment
122,400
179,800
223,500
178,800
Acquisitions
656,000
19,900
0
546,800
Proceeds from sale of passport
0
6,600
-
0
Proceeds from sale of vitamin business
160,300
-
-
-
Other
-1,200
-9,800
10,800
3,000
Net cash used in investing activities
-616,900
-183,300
-234,300
-728,600
Long-term debt borrowings
-
0
0
998,800
Repayments of long-term debt
0
204,600
200,000
700,000
Short-term debt (repayments), net of borrowings
0
-3,600
-70,600
-178,900
Proceeds from stock options exercised
35,600
142,900
111,700
26,200
Payment of cash dividends
287,200
277,000
266,500
255,000
Purchase of treasury stock
900,000
0
300,100
0
Payment of business acquisition liabilities
-
-
-
0
Payment of business acquisition liability
-5,900
-
-
-
Deferred financing and other
-
1,100
100
12,000
Other
-4,900
-
-
-
Net cash used in financing activities
-1,162,400
-343,400
-725,600
-120,900
Effect of exchange rate changes on cash and cash equivalents
8,800
-9,900
3,500
-6,000
Net change in cash and cash equivalents
-555,100
619,600
74,200
29,700
Cash and cash equivalents at beginning of period
964,100
344,500
270,300
240,600
Cash and cash equivalents at end of period
409,000
964,100
344,500
270,300
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$736,800K
(25.88%↑ Y/Y)
Amortization expense
$157,700K
(1.15%↑ Y/Y)
Depreciation expense
$89,700K
(7.81%↑ Y/Y)
Loss on sale of
vitamin business
-$58,500K
Non-cash compensation
expense
$58,000K
(-2.03%↓ Y/Y)
Business exit related
impairments
$45,600K
Deferred income taxes
$36,000K
(143.90%↑ Y/Y)
Change in fair value of
business acquisition...
$19,000K
Asset impairment
charge and other asset...
$10,100K
(-16.53%↓ Y/Y)
Inventories
-$56,100K
(-2705.00%↓ Y/Y)
Distributions from
unconsolidated affiliates
$8,800K
(-1.12%↓ Y/Y)
Accounts receivable
-$39,400K
(-148.34%↓ Y/Y)
Accounts payable
$2,400K
(-97.57%↓ Y/Y)
Other current assets
-$1,200K
(-340.00%↓ Y/Y)
Subtotal
$1,205,600K
Change in working
capital
-$9,800K
Canceled cashflow
$14,600K
Canceled cashflow
$89,300K
Net cash provided by
operating activities
$1,215,400K
(5.12%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$8,800K
(188.89%↑ Y/Y)
Equity in net earnings
of affiliates
$7,900K
(-13.19%↓ Y/Y)
Other
$6,700K
(8.06%↑ Y/Y)
Accrued expenses
-$60,900K
(-5436.36%↓ Y/Y)
Other operating
assets and...
$23,300K
(25.27%↑ Y/Y)
Income taxes payable
-$5,100K
(28.17%↑ Y/Y)
Net change in cash
and cash...
-$555,100K
(-189.59%↓ Y/Y)
Canceled cashflow
$1,224,200K
Proceeds from stock
options exercised
$35,600K
(-75.09%↓ Y/Y)
Proceeds from sale of
vitamin business
$160,300K
Other
-$1,200K
(87.76%↑ Y/Y)
Net cash used in
financing activities
-$1,162,400K
(-238.50%↓ Y/Y)
Canceled cashflow
$35,600K
Net cash used in
investing activities
-$616,900K
(-236.55%↓ Y/Y)
Canceled cashflow
$161,500K
Purchase of treasury
stock
$900,000K
Payment of cash
dividends
$287,200K
(3.68%↑ Y/Y)
Payment of business
acquisition liability
-$5,900K
Other
-$4,900K
(50.00%↑ Y/Y)
Acquisitions
$656,000K
(3196.48%↑ Y/Y)
Additions to property,
plant and equipment
$122,400K
(-31.92%↓ Y/Y)
Buy us a coffee
2023-Sustainability-Report-34-pdf-svg
CHURCH & DWIGHT CO INC DE (CHD)
2023-Sustainability-Report-34-pdf-svg
CHURCH & DWIGHT CO INC DE (CHD)